Back
Day Range
$3.18
$3.40
52-Week Range
$0.53
$5.78
Volume
2,291,609
50D / 200D Avg
$4.21
/
$2.36
Prev Close
$3.04
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 22.3 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 8.1 | 3.8 |
| Rev Growth 5Y % | -8.0 | 10.0 |
| D/E | — | 0.2 |
Key Takeaways
Revenue declined -8.02% annually over 5 years
Earnings grew 2629.20% over the past year
Generating 127.01M in free cash flow
PEG of 0.01 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.70%
Cash machine — converts 528.83% of earnings into free cash flow
Growth
Revenue Growth (5Y)
-8.02%
Revenue (1Y)-15.72%
Earnings (1Y)2629.20%
FCF Growth (3Y)-16.73%
Quality
Return on Equity
N/A
ROIC26.51%
Net Margin8.11%
Op. Margin40.10%
Safety
Debt / Equity
N/A
Current Ratio1.13
Interest Coverage3.63
Valuation
P/E Ratio
22.34
P/B RatioN/A
EV/EBITDA7.74
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -15.72% | Revenue Growth (3Y) | -18.21% |
| Earnings Growth (1Y) | 2629.20% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -8.02% | Earnings Growth (5Y) | -53.83% |
| Profitability | |||
| Revenue (TTM) | 296.15M | Net Income (TTM) | 24.02M |
| ROE | N/A | ROA | 6.05% |
| Gross Margin | 99.36% | Operating Margin | 40.10% |
| Net Margin | 8.11% | Free Cash Flow (TTM) | 127.01M |
| ROIC | 26.51% | FCF Growth (3Y) | -16.73% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.13 |
| Interest Coverage | 3.63 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 22.34 | P/B Ratio | N/A |
| P/S Ratio | 1.81 | PEG Ratio | 0.01 |
| EV/EBITDA | 7.74 | Dividend Yield | 0.00% |
| Market Cap | 536.46M | Enterprise Value | 918.81M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 296.15M | 351.41M | 442.74M | 410.60M | 413.75M |
| Net Income | 24.02M | 880,000.0 | -1.00B | 175.07M | 528.45M |
| EPS (Diluted) | 0.15 | 0.01 | -6.45 | 0.96 | 3.21 |
| Gross Profit | 294.27M | 343.86M | 436.59M | 409.18M | 343.35M |
| Operating Income | 118.76M | 93.12M | -945.43M | 250.34M | 232.26M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 396.90M | 350.91M | 471.07M | 1.10B | 1.13B |
| Total Liabilities | 658.74M | 652.24M | 817.37M | 448.14M | 521.02M |
| Shareholders' Equity | -261.83M | -301.34M | -346.30M | 652.38M | 605.91M |
| Total Debt | 597.80M | 599.48M | 715.54M | 415.92M | 475.80M |
| Cash & Equivalents | 215.46M | 88.56M | 92.15M | 656.20M | 620.13M |
| Current Assets | 274.18M | 182.37M | 233.29M | 780.63M | 745.23M |
| Current Liabilities | 242.22M | 38.85M | 276.10M | 25.53M | 161.70M |